Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 789

1.

Perfusion abnormality on three-dimensional arterial spin labeling in patients with acute encephalopathy with biphasic seizures and late reduced diffusion.

Uetani H, Kitajima M, Sugahara T, Muto Y, Hirai K, Kuroki Y, Nakaura T, Tateishi M, Yamashita Y.

J Neurol Sci. 2019 Nov 1;408:116558. doi: 10.1016/j.jns.2019.116558. [Epub ahead of print]

PMID:
31715327
2.

[METASTATIC Mucinous Tubular and Spindle Cell Carcinoma Treated with Nivolumab Successfully : A Case Report].

Takahashi Y, Numakura K, Aoyama Y, Okada S, Saito T, Muto Y, Koizumi A, Nara T, Chiba S, Kanda S, Saito M, Narita S, Inoue T, Satoh S, Nanjo H, Habuchi T.

Hinyokika Kiyo. 2019 Sep;65(9):363-367. doi: 10.14989/ActaUrolJap_65_9_363. Japanese.

PMID:
31697878
3.

Bullous pemphigoid induced by pembrolizumab in a patient with non-small-cell lung cancer who achieved durable complete response despite treatment cessation and long-term corticosteroid administration: A case report.

Muto Y, Namikawa K, Fujiwara Y, Mori T, Nakano E, Takahashi A, Yamazaki N.

J Dermatol. 2019 Oct 31. doi: 10.1111/1346-8138.15140. [Epub ahead of print] No abstract available.

PMID:
31674068
4.

A case of corrosive esophagitis causing extensive cicatricial esophageal stenosis treated by esophageal bypass with supercharged pedicled jejunal pull-up.

Saito M, Kiyozaki H, Obitsu T, Machida E, Takahashi J, Abe I, Muto Y, Rikiyama T.

Int J Surg Case Rep. 2019;64:143-146. doi: 10.1016/j.ijscr.2019.10.021. Epub 2019 Oct 17.

5.

Japanese real-world study of sequential nivolumab and ipilimumab treament in melanoma.

Tsutsumida A, Fukushima S, Yokota K, Yoshikawa S, Yamasaki O, Tanemura A, Okuyama R, Uhara H, Muto Y, Miyashita A, Akiyama M, Kaji T, Koga H, Kato J, Katayama T, Itakura E, Yamazaki N, Kiyohara Y.

J Dermatol. 2019 Nov;46(11):947-955. doi: 10.1111/1346-8138.15073. Epub 2019 Sep 17.

PMID:
31531895
6.

[Clinical Significance of Ipilimumab and the Combination Therapy as Immune Checkpoint Inhibitor].

Muto Y, Kitano S.

Gan To Kagaku Ryoho. 2019 Jun;46(6):1011-1015. Japanese.

PMID:
31273167
7.

Nivolumab for patients with metastatic uveal melanoma previously untreated with ipilimumab: a single-institution retrospective study.

Namikawa K, Takahashi A, Mori T, Tsutsumida A, Suzuki S, Motoi N, Jinnai S, Kage Y, Mizuta H, Muto Y, Nakano E, Yamazaki N.

Melanoma Res. 2019 May 14. doi: 10.1097/CMR.0000000000000617. [Epub ahead of print]

PMID:
31095037
8.

Reduced Folate Carrier: an Entry Receptor for a Novel Feline Leukemia Virus Variant.

Miyake A, Kawasaki J, Ngo H, Makundi I, Muto Y, Khan AH, Smith DJ, Nishigaki K.

J Virol. 2019 Jun 14;93(13). pii: e00269-19. doi: 10.1128/JVI.00269-19. Print 2019 Jul 1.

PMID:
30996094
9.

Long-term outcomes in Japanese nonagenarians undergoing transcatheter aortic valve implantation: A multi-center analysis.

Yokoyama H, Tobaru T, Muto Y, Hagiya K, Higuchi R, Saji M, Takamisawa I, Shimizu J, Takanashi S, Takayama M, Tomita H, Tamura H, Doi S, Okazaki S, Isobe M.

Clin Cardiol. 2019 Jun;42(6):605-611. doi: 10.1002/clc.23183. Epub 2019 Apr 23.

10.

Multiple primary malignancies of six organs in a Japanese male patient: A case report.

Muto Y, Suzuki K, Kato T, Ichida K, Takayama Y, Fukui T, Kakizawa N, Watanabe F, Kaneda Y, Noda H, Rikiyama T.

Mol Clin Oncol. 2019 May;10(5):511-515. doi: 10.3892/mco.2019.1819. Epub 2019 Mar 4.

11.

Investigation of clinical factors associated with longer overall survival in advanced melanoma patients treated with sequential ipilimumab.

Muto Y, Kitano S, Tsutsumida A, Namikawa K, Takahashi A, Nakamura Y, Yamanaka T, Yamamoto N, Yamazaki N.

J Dermatol. 2019 Jun;46(6):498-506. doi: 10.1111/1346-8138.14865. Epub 2019 Apr 4.

PMID:
30945333
12.

Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis.

Muto Y, Moroishi T, Ichihara K, Nishiyama M, Shimizu H, Eguchi H, Moriya K, Koike K, Mimori K, Mori M, Katayama Y, Nakayama KI.

J Exp Med. 2019 Apr 1;216(4):950-965. doi: 10.1084/jem.20180900. Epub 2019 Mar 15.

13.

Genome-wide analyses reveal genes subject to positive selection in Toxoplasma gondii.

Yoshizaki S, Akahori H, Umemura T, Terada T, Takashima Y, Muto Y.

Gene. 2019 May 30;699:73-79. doi: 10.1016/j.gene.2019.03.008. Epub 2019 Mar 9.

PMID:
30858136
14.

Different Response Profiles of Gastrointestinal Cancer Cells to an L-Type Amino Acid Transporter Inhibitor, JPH203.

Muto Y, Furihata T, Kaneko M, Higuchi K, Okunushi K, Morio H, Reien Y, Uesato M, Matsubara H, Anzai N.

Anticancer Res. 2019 Jan;39(1):159-165. doi: 10.21873/anticanres.13092.

PMID:
30591453
15.

A conditionally immortalized Gli1-positive kidney mesenchymal cell line models myofibroblast transition.

Ó hAinmhire E, Wu H, Muto Y, Donnelly EL, Machado FG, Fan LX, Chang-Panesso M, Humphreys BD.

Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F63-F75. doi: 10.1152/ajprenal.00460.2018. Epub 2018 Oct 10.

PMID:
30303712
16.

Perfusion abnormality on three-dimensional arterial spin labeling with a 3T MR system in pediatric and adolescent patients with migraine.

Uetani H, Kitajima M, Sugahara T, Kikuchi H, Muto Y, Hirahara T, Tateishi M, Kuroki Y, Yamashita Y.

J Neurol Sci. 2018 Dec 15;395:41-46. doi: 10.1016/j.jns.2018.09.024. Epub 2018 Sep 28.

PMID:
30290298
17.

Monitoring circulating tumor DNA revealed dynamic changes in KRAS status in patients with metastatic colorectal cancer.

Takayama Y, Suzuki K, Muto Y, Ichida K, Fukui T, Kakizawa N, Ishikawa H, Watanabe F, Hasegawa F, Saito M, Tsujinaka S, Futsuhara K, Miyakura Y, Noda H, Konishi F, Rikiyama T.

Oncotarget. 2018 May 11;9(36):24398-24413. doi: 10.18632/oncotarget.25309. eCollection 2018 May 11.

18.

Overexpression of satellite alpha transcripts leads to chromosomal instability via segregation errors at specific chromosomes.

Ichida K, Suzuki K, Fukui T, Takayama Y, Kakizawa N, Watanabe F, Ishikawa H, Muto Y, Kato T, Saito M, Futsuhara K, Miyakura Y, Noda H, Ohmori T, Konishi F, Rikiyama T.

Int J Oncol. 2018 Mar 16. doi: 10.3892/ijo.2018.4321. [Epub ahead of print]

PMID:
29568894
19.

[Optimal Dissection of the Intestinal Tract and Preservation of Vascular Supply in Left Hemicolectomy Using Simulation Computed Tomography Colonography].

Narushima K, Miyauchi H, Ohira G, Hayano K, Kagaya A, Muto Y, Imanishi S, Kurata Y, Takahashi Y, Sawada N, Watanabe H, Matsubara H.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1847-1849. Japanese.

PMID:
29394796
20.

[An Elderly Patient with Metastatic Colon Cancer Achieved Long-Term Survival Following Single-Agent Chemotherapy with S-1].

Muto Y, Chochi K, Morita D, Oka A, Rikiyama T.

Gan To Kagaku Ryoho. 2018 Jan;45(1):55-57. Japanese.

PMID:
29362308
21.

Success of rechallenging dabrafenib and trametinib combination therapy after trametinib-induced rhabdomyolysis: a case report.

Muto Y, Ng W, Namikawa K, Takahashi A, Tsutsumida A, Nishida M, Yamazaki N.

Melanoma Res. 2018 Apr;28(2):151-154. doi: 10.1097/CMR.0000000000000424.

PMID:
29356791
22.

Sensitivity and specificity of QuantiFERON-TB Gold Plus compared with QuantiFERON-TB Gold In-Tube and T-SPOT.TB on active tuberculosis in Japan.

Takasaki J, Manabe T, Morino E, Muto Y, Hashimoto M, Iikura M, Izumi S, Sugiyama H, Kudo K.

J Infect Chemother. 2018 Mar;24(3):188-192. doi: 10.1016/j.jiac.2017.10.009. Epub 2017 Nov 3.

PMID:
29108749
23.

Spatial variations of tritium concentrations in groundwater collected in the southern coastal region of Fukushima, Japan, after the nuclear accident.

Kashiwaya K, Muto Y, Kubo T, Ikawa R, Nakaya S, Koike K, Marui A.

Sci Rep. 2017 Oct 3;7(1):12578. doi: 10.1038/s41598-017-12840-3.

24.

Comparison of Efficacy of Self-Expandable Metallic Stent Placement in the Unresectable Esophageal Cancer Patients.

Uesato M, Akutsu Y, Murakami K, Muto Y, Kagaya A, Nakano A, Aikawa M, Tamachi T, Arasawa T, Amagai H, Muto Y, Matsubara H.

Gastroenterol Res Pract. 2017;2017:2560510. doi: 10.1155/2017/2560510. Epub 2017 Jul 27.

25.

Endoscopic occlusion with silicone spigots for the closure of refractory esophago-bronchiole fistula after esophagectomy.

Uesato M, Kono T, Akutsu Y, Murakami K, Kagaya A, Muto Y, Nakano A, Aikawa M, Tamachi T, Amagai H, Arasawa T, Muto Y, Matsubara H.

World J Gastroenterol. 2017 Jul 28;23(28):5253-5256. doi: 10.3748/wjg.v23.i28.5253.

26.

Morphological response contributes to patient selection for rescue liver resection in chemotherapy patients with initially un-resectable colorectal liver metastasis.

Suzuki K, Muto Y, Ichida K, Fukui T, Takayama Y, Kakizawa N, Kato T, Hasegawa F, Watanabe F, Kaneda Y, Kikukawa R, Saito M, Tsujinaka S, Futsuhara K, Takata O, Noda H, Miyakura Y, Kiyozaki H, Konishi F, Rikiyama T.

Oncol Lett. 2017 Aug;14(2):1491-1499. doi: 10.3892/ol.2017.6338. Epub 2017 Jun 7.

27.

Essential role of FBXL5-mediated cellular iron homeostasis in maintenance of hematopoietic stem cells.

Muto Y, Nishiyama M, Nita A, Moroishi T, Nakayama KI.

Nat Commun. 2017 Jul 17;8:16114. doi: 10.1038/ncomms16114.

28.

Sequential administration of XELOX and XELIRI is effective, feasible and well tolerated by patients with metastatic colorectal cancer.

Fukui T, Suzuki K, Ichida K, Takayama Y, Kakizawa N, Muto Y, Hasegawa F, Watanabe F, Kikugawa R, Saito M, Tsujinaka S, Miyakura Y, Rikiyama T.

Oncol Lett. 2017 Jun;13(6):4947-4952. doi: 10.3892/ol.2017.6100. Epub 2017 Apr 26.

29.

High-risk cutaneous squamous cell carcinoma in a Japanese allogeneic bone marrow transplant recipient on long-term voriconazole.

Ng W, Takahashi A, Muto Y, Yamazaki N.

J Dermatol. 2017 Oct;44(10):1152-1155. doi: 10.1111/1346-8138.13867. Epub 2017 May 4. Review.

PMID:
28470790
30.

Extranuclear Translocation of High-Mobility Group A1 Reduces the Invasion of Extravillous Trophoblasts Involved in the Pathogenesis of Preeclampsia: New Aspect of High-Mobility Group A1.

Uchikura Y, Matsubara K, Muto Y, Matsubara Y, Fujioka T, Matsumoto T, Sugiyama T.

Reprod Sci. 2017 Dec;24(12):1630-1638. doi: 10.1177/1933719117697254. Epub 2017 Mar 27.

PMID:
28345487
31.

Clinical and molecular assessment of regorafenib monotherapy.

Kakizawa N, Suzuki K, Fukui T, Takayama Y, Ichida K, Muto Y, Hasegawa F, Watanabe F, Kikugawa R, Tsujinaka S, Futsuhara K, Miyakura Y, Noda H, Rikiyama T.

Oncol Rep. 2017 Apr;37(4):2506-2512. doi: 10.3892/or.2017.5456. Epub 2017 Feb 15.

PMID:
28259999
32.

The modern Japanese color lexicon.

Kuriki I, Lange R, Muto Y, Brown AM, Fukuda K, Tokunaga R, Lindsey DT, Uchikawa K, Shioiri S.

J Vis. 2017 Mar 1;17(3):1. doi: 10.1167/17.3.1.

PMID:
28249298
33.

Heterotrimeric G protein Gαs subunit attenuates PLEKHG2, a Rho family-specific guanine nucleotide exchange factor, by direct interaction.

Sugiyama K, Tago K, Matsushita S, Nishikawa M, Sato K, Muto Y, Nagase T, Ueda H.

Cell Signal. 2017 Apr;32:115-123. doi: 10.1016/j.cellsig.2017.01.022. Epub 2017 Jan 17.

PMID:
28108261
34.

Solution structure of the first RNA recognition motif domain of human spliceosomal protein SF3b49 and its mode of interaction with a SF3b145 fragment.

Kuwasako K, Nameki N, Tsuda K, Takahashi M, Sato A, Tochio N, Inoue M, Terada T, Kigawa T, Kobayashi N, Shirouzu M, Ito T, Sakamoto T, Wakamatsu K, Güntert P, Takahashi S, Yokoyama S, Muto Y.

Protein Sci. 2017 Feb;26(2):280-291. doi: 10.1002/pro.3080. Epub 2016 Nov 27.

35.

Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials.

Isomura T, Suzuki S, Origasa H, Hosono A, Suzuki M, Sawada T, Terao S, Muto Y, Koga T.

Eur J Clin Nutr. 2016 Nov;70(11):1340. doi: 10.1038/ejcn.2016.165. No abstract available.

PMID:
27805619
36.

Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials.

Isomura T, Suzuki S, Origasa H, Hosono A, Suzuki M, Sawada T, Terao S, Muto Y, Koga T.

Eur J Clin Nutr. 2016 Nov;70(11):1221-1229. doi: 10.1038/ejcn.2016.78. Epub 2016 May 18. Review. Erratum in: Eur J Clin Nutr. 2016 Nov;70(11):1340.

37.

Clinical characteristics of synchronous colorectal cancers in Japan.

Kato T, Alonso S, Muto Y, Noda H, Miyakura Y, Suzuki K, Tsujinaka S, Saito M, Perucho M, Rikiyama T.

World J Surg Oncol. 2016 Oct 24;14(1):272.

38.

Drill needle aspiration biopsy for submucosal tumors in an experimental study.

Uesato M, Tamachi T, Hanari N, Muto Y, Kagaya A, Urahama R, Ogura Y, Suito H, Nakano A, Aikawa M, Oide T, Matsubara H.

Gastric Cancer. 2017 May;20(3):475-480. doi: 10.1007/s10120-016-0630-4. Epub 2016 Aug 16.

39.

Assessment for diagnosis of lymph node metastasis in esophageal cancer using endoscopic ultrasound elastography.

Sazuka T, Akai T, Uesato M, Horibe D, Kuboshima M, Kitabayashi H, Matsunaga A, Kagaya A, Muto Y, Takeshita N, Maruyama T, Miyazawa Y, Shuto K, Shiratori T, Kono T, Akutsu Y, Hoshino I, Matsubara H.

Esophagus. 2016;13:254-263. Epub 2016 Jan 29.

40.

Increase in ozone due to the use of biodiesel fuel rather than diesel fuel.

Thang PQ, Muto Y, Maeda Y, Trung NQ, Itano Y, Takenaka N.

Environ Pollut. 2016 Sep;216:400-407. doi: 10.1016/j.envpol.2016.04.102. Epub 2016 Jul 5.

PMID:
27396671
41.

A probabilistic bridge safety evaluation against floods.

Liao KW, Muto Y, Chen WL, Wu BH.

Springerplus. 2016 Jun 18;5(1):783. doi: 10.1186/s40064-016-2366-3. eCollection 2016.

42.

Heterogeneous expression of zinc-finger E-box-binding homeobox 1 plays a pivotal role in metastasis via regulation of miR-200c in epithelial-mesenchymal transition.

Muto Y, Suzuki K, Kato T, Tsujinaka S, Ichida K, Takayama Y, Fukui T, Kakizawa N, Watanabe F, Saito M, Futsuhara K, Noda H, Miyakura Y, Konishi F, Rikiyama T.

Int J Oncol. 2016 Sep;49(3):1057-67. doi: 10.3892/ijo.2016.3583. Epub 2016 Jun 17.

PMID:
27315529
43.

A case of recurrent malignant triton tumor successfully treated with radiotherapy.

Yasuda M, Muto Y, Kuremoto T, Murakami K, Onisihi T, Koida A, Inui T, Hisa Y.

Auris Nasus Larynx. 2016 Dec;43(6):710-4. doi: 10.1016/j.anl.2016.04.003. Epub 2016 Apr 15.

PMID:
27146005
44.

Malignant, but not benign, intraductal papillary mucinous neoplasm preferentially associates with prior extrapancreatic malignancies.

Kato T, Alonso S, Noda H, Miyakura Y, Tsujinaka S, Saito M, Muto Y, Fukui T, Ichida K, Takayama Y, Watanabe F, Kakizawa N, Perucho M, Rikiyama T.

Oncol Rep. 2016 Jun;35(6):3236-40. doi: 10.3892/or.2016.4755. Epub 2016 Apr 19.

PMID:
27108615
45.

Structure, Dynamics, and Interaction of p54(nrb)/NonO RRM1 with 5' Splice Site RNA Sequence.

Duvignaud JB, Bédard M, Nagata T, Muto Y, Yokoyama S, Gagné SM, Vincent M.

Biochemistry. 2016 May 10;55(18):2553-66. doi: 10.1021/acs.biochem.5b01240. Epub 2016 Apr 26.

PMID:
27064654
46.

FBXL12 regulates T-cell differentiation in a cell-autonomous manner.

Nita A, Nishiyama M, Muto Y, Nakayama KI.

Genes Cells. 2016 May;21(5):517-24. doi: 10.1111/gtc.12360. Epub 2016 Mar 21.

47.

Improved clinical outcome and biomarkers in adults with papulopustular rosacea treated with doxycycline modified-release capsules in a randomized trial.

Di Nardo A, Holmes AD, Muto Y, Huang EY, Preston N, Winkelman WJ, Gallo RL.

J Am Acad Dermatol. 2016 Jun;74(6):1086-92. doi: 10.1016/j.jaad.2016.01.023. Epub 2016 Mar 5.

PMID:
26951940
48.

A case of giant ileal duplication in an adult, successfully treated with laparoscope-assisted surgery.

Matsumoto Y, Tohma T, Miyauchi H, Suzuki K, Nishimori T, Ohira G, Narushima K, Muto Y, Maruyama T, Matsubara H.

Surg Case Rep. 2015 Dec;1(1):10. doi: 10.1186/s40792-015-0019-3. Epub 2015 Jan 30.

49.

Tumor size is an independent risk predictor for metachronous colorectal cancer.

Kato T, Alonso S, Muto Y, Perucho M, Rikiyama T.

Oncotarget. 2016 Apr 5;7(14):17896-904. doi: 10.18632/oncotarget.7555.

50.

Potential risk factors for onset of severe neck and shoulder discomfort (Katakori) in urban Japanese workers.

Sawada T, Matsudaira K, Muto Y, Koga T, Takahashi M.

Ind Health. 2016 Jun 10;54(3):230-6. doi: 10.2486/indhealth.2015-0143. Epub 2016 Jan 30.

Supplemental Content

Support Center